Amount Raised
$21 Million
Round Type
Funding Round
CarlsbadManufacturingBiotechnologyTherapeuticsInvestors
Description
On November 12, 2025, Lineage Cell Therapeutics, Inc. sold 12,000,000 common shares to Janus Henderson Investors at a purchase price of $1.75 per share. This transaction was executed under the company's at-the-market offering program. The gross proceeds received amounted to $21 million before any fees or expenses.
Quick answer
Lineage Cell Therapeutics raised $21 Million in a Funding Round round, dated November 12, 2025. Investors: Janus Henderson Investors. Lineage Cell Therapeutics is based in Carlsbad, California, United States.
- How much did Lineage Cell Therapeutics raise?
- Lineage Cell Therapeutics raised $21 Million in a Funding Round round on November 12, 2025.
- Who invested in Lineage Cell Therapeutics?
- Janus Henderson Investors is named as investors in this round.
- What does Lineage Cell Therapeutics do?
- Lineage Cell Therapeutics is a clinical-stage biotechnology company developing novel or 'off-the-shelf,' cell therapies to address unmet medical needs.
- Where is Lineage Cell Therapeutics based and how big is it?
- Lineage Cell Therapeutics is based in Carlsbad, California, United States. Fundz records about 70 employees.
- Who are the decision-makers at Lineage Cell Therapeutics?
- Fundz holds 5 contacts at Lineage Cell Therapeutics, including the Founder and CEO. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Therapeutics and Manufacturing around the same time
Companies in the same sectors as Lineage Cell Therapeutics that raised within 45 days of this round, from Fundz verified event records.
- CASI Pharmaceuticals raised $5M on December 27, 2025.
- MEDIPOST raised $140M (Convertible Note) on December 18, 2025.
- Virax Biolabs raised $5M (Post-IPO Equity) on December 3, 2025.
- SymPhysis Medical raised $1.3M (Grant) on November 26, 2025.
- Intensity Therapeutics raised $4M (Post-IPO Equity) on October 31, 2025.
- Smartlens raised $5.2M (Funding Round) on October 14, 2025.
Who to call at Lineage Cell Therapeutics, and when
A new round usually means Lineage Cell Therapeutics is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Lineage Cell Therapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Lineage Cell Therapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Lineage Cell Therapeutics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Lineage Cell Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Lineage Cell Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.